183 related articles for article (PubMed ID: 2802558)
1. beta-Lactamase stability and in vitro activity of oral cephalosporins against strains possessing well-characterized mechanisms of resistance.
Sanders CC
Antimicrob Agents Chemother; 1989 Aug; 33(8):1313-7. PubMed ID: 2802558
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of ceftazidime and other cephalosporins to a range of beta-lactamases and their potential as inducing agents.
Mouton RP; Bongaerts GP; van Gestel MH
J Antimicrob Chemother; 1981 Sep; 8 Suppl B():147-52. PubMed ID: 19802978
[TBL] [Abstract][Full Text] [Related]
3. In vitro studies with Bay V 3522, a new oral cephalosporin.
Thomson KS; Sanders CC; Sanders WE
Drugs Exp Clin Res; 1991; 17(3):165-73. PubMed ID: 1914843
[TBL] [Abstract][Full Text] [Related]
4. Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase.
Bush K; Flamm RK; Ohringer S; Singer SB; Summerill R; Bonner DP
Antimicrob Agents Chemother; 1991 Nov; 35(11):2203-8. PubMed ID: 1803992
[TBL] [Abstract][Full Text] [Related]
5. The in-vitro activity of cefdinir (FK482), a new oral cephalosporin.
Wise R; Andrews JM; Thornber D
J Antimicrob Chemother; 1991 Aug; 28(2):239-48. PubMed ID: 1778855
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial activity of ceftizoxime (FK 749), a new cephalosporin, against cephalosporin-resistant bacteria, and its stability to beta-lactamase.
Kojo H; Nishida M; Goto S; Kuwahara S
Antimicrob Agents Chemother; 1979 Nov; 16(5):549-53. PubMed ID: 316684
[TBL] [Abstract][Full Text] [Related]
8. Cefaclor: in vitro spectrum of activity and beta-lactamase stability.
Neu HC; Fu KP
Antimicrob Agents Chemother; 1978 Apr; 13(4):584-8. PubMed ID: 666290
[TBL] [Abstract][Full Text] [Related]
9. Ceftibuten: a new orally absorbed cephalosporin. In vitro activity against strains from the United Kingdom.
Wise R; Andrews JM; Ashby JP; Thornber D
Diagn Microbiol Infect Dis; 1991; 14(1):45-52. PubMed ID: 2013210
[TBL] [Abstract][Full Text] [Related]
10. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
Medeiros AA; Hare R; Papa E; Adam C; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
[TBL] [Abstract][Full Text] [Related]
11. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
12. Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
Cullmann W; Dick W; Stieglitz M; Opferkuch W
Chemotherapy; 1988; 34(3):202-15. PubMed ID: 3262045
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):671-7. PubMed ID: 3260766
[TBL] [Abstract][Full Text] [Related]
14. Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs.
Schito GC; Pesce A; Debbia EA
Drugs; 1994; 47 Suppl 3():1-8; discussion 8-9. PubMed ID: 7518761
[TBL] [Abstract][Full Text] [Related]
15. The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics.
Neu HC; Chin NX
Chemioterapia; 1985 Aug; 4(4):271-7. PubMed ID: 3876887
[TBL] [Abstract][Full Text] [Related]
16. The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins.
Wise R; Andrews JM; Ashby JP; Thornber D
J Antimicrob Chemother; 1990 Apr; 25(4):541-50. PubMed ID: 2351624
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of FCE 22101 and other beta-lactam antibiotics against Enterobacteriaceae resistant to third generation cephalosporins.
Jarlier V; Nicolas MH; Philippon A; Giroir AM; Grosset J
J Antimicrob Chemother; 1989 Aug; 24(2):165-72. PubMed ID: 2676939
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates.
Jones RN; Fuchs PC; Barry AL; Ayers LW; Gerlach EH; Gavan TL
Antimicrob Agents Chemother; 1986 Dec; 30(6):961-3. PubMed ID: 3492961
[TBL] [Abstract][Full Text] [Related]
19. Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.
Then RL; Angehrn P
Antimicrob Agents Chemother; 1982 May; 21(5):711-7. PubMed ID: 6808912
[TBL] [Abstract][Full Text] [Related]
20. Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.
Sanders CC; Sanders WE
Antimicrob Agents Chemother; 1979 Jun; 15(6):792-7. PubMed ID: 314270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
